Page last updated: 2024-08-23

bromocriptine and methylergonovine

bromocriptine has been researched along with methylergonovine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ruckebusch, Y1
Akaike, A; Izumi, Y; Kume, T; Niidome, T; Oda, T; Takada-Takatori, Y1

Reviews

1 review(s) available for bromocriptine and methylergonovine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for bromocriptine and methylergonovine

ArticleYear
Enhancement of the cyclic motor activity of the ovine small intestine by lysergic acid derivatives. Mechanism and significance.
    Gastroenterology, 1984, Volume: 87, Issue:5

    Topics: Action Potentials; Animals; Bromocriptine; Duodenum; Ergolines; Gastrointestinal Motility; Intestine, Small; Lysergic Acid; Methylergonovine; Methysergide; Periodicity; Pyloric Antrum; Serotonin; Serotonin Antagonists; Sheep; Vagotomy

1984
Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
    European journal of pharmacology, 2008, Nov-19, Volume: 598, Issue:1-3

    Topics: Animals; Azepines; Benzothiazoles; Blotting, Western; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergonovine; Ergot Alkaloids; Methylergonovine; Mitogen-Activated Protein Kinases; Neurites; PC12 Cells; Pramipexole; Rats; Receptors, Dopamine D2

2008